首页> 美国卫生研究院文献>other >Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors
【2h】

Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors

机译:抢先和非抢先移植的患者与活体肾脏供体相比在肾移植之前显示出相当的高凝状态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To prevent renal graft thrombosis in kidney transplantation, centres use different perioperative anticoagulant strategies, based on various risk factors. In our centre, patients transplanted preemptively are considered at increased risk of renal graft thrombosis compared to patients who are dialysis-dependent at time of transplantation. Therefore these patients are given a single dose of 5000 IU unfractionated heparin intraoperatively before clamping of the vessels. We questioned whether there is a difference in haemostatic state between preemptively and non-preemptively transplanted patients and whether the distinction in intraoperative heparin administration used in our center is justified. For this analysis, citrate samples of patients participating in the VAPOR-1 trial were used and several haemostatic and fibrinolytic parameters were measured in 29 preemptively and 28 non-preemptively transplanted patients and compared to 37 living kidney donors. Sample points were: induction anaesthesia (T1), 5 minutes after reperfusion (T2) and 2 hours postoperative (T3). At T1, recipient groups showed comparable elevated levels of platelet factor 4 (PF4, indicating platelet activation), prothrombin fragment F1+2 and D-dimer (indicating coagulation activation) and Von Willebrand Factor (indicating endothelial activation) compared to the donors. The Clot Lysis Time (CLT, a measure of fibrinolytic potential) was prolonged in both recipient groups compared to the donors. At T3, F1+2, PF4 and CLT were higher in non-preemptively transplanted recipients compared to preemptively transplanted recipients. Compared to donors, non-preemptive recipients showed a prolonged CLT, but comparable levels of PF4 and D-dimer. In conclusion pre-transplantation, preemptively and non-preemptively transplanted patients show a comparable enhanced haemostatic state. A distinction in intraoperative heparin administration between preemptive and non-preemptive transplantation does not seem justified.
机译:为了防止肾脏移植中的肾移植血栓形成,各中心根据各种危险因素使用不同的围手术期抗凝策略。在我们中心,与移植时依赖透析的患者相比,提前移植的患者被认为肾移植血栓形成的风险增加。因此,在夹住血管之前,应向这些患者术中给予5000 IU普通肝素单剂量。我们询问先行移植和未先行移植患者的止血状态是否存在差异,以及我们中心使用术中肝素管理的区别是否合理。为了进行该分析,使用了参加VAPOR-1试验的患者的柠檬酸盐样品,并在29位先发性移植患者和28位非先发性移植患者中测量了几种止血和纤溶参数,并与37名活体肾脏供体进行了比较。样本点为:诱导麻醉(T1),再灌注后5分钟(T2)和术后2小时(T3)。与捐献者相比,在T1时,接受者组的血小板因子4(PF4,表明血小板活化),凝血酶原片段F1 + 2和D-二聚体(指示凝血活化)和冯·威兰布兰德因子(指示内皮活化)水平升高。与捐献者相比,两个接受者群体的血栓溶解时间(CLT,一种纤溶潜能的量度)均延长。在T3时,非先行移植接受者的F1 + 2,PF4和CLT高于先行移植接受者。与捐献者相比,非抢先接受者表现出更长的CLT,但可与PF4和D-二聚体水平相当。总之,在移植前,先发性和非先发性移植患者均表现出类似的止血状态。术中肝素给药在先发性移植和非先发性移植之间的区别似乎没有道理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号